Logo image of MAXN

MAXEON SOLAR TECHNOLOGIE (MAXN) Stock Fundamental Analysis

NASDAQ:MAXN - Nasdaq - SGXZ57724486 - Common Stock - Currency: USD

3.07  +0.03 (+0.99%)

Fundamental Rating

1

MAXN gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the profitability and financial health of MAXN have multiple concerns. MAXN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MAXN had negative earnings in the past year.
In the past year MAXN has reported a negative cash flow from operations.
In the past 5 years MAXN always reported negative net income.
MAXN had negative operating cash flow in 4 of the past 5 years.
MAXN Yearly Net Income VS EBIT VS OCF VS FCFMAXN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

MAXN has a worse Return On Assets (-151.06%) than 97.27% of its industry peers.
Industry RankSector Rank
ROA -151.06%
ROE N/A
ROIC N/A
ROA(3y)-70.69%
ROA(5y)-50.14%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MAXN Yearly ROA, ROE, ROICMAXN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 5K 10K 15K 20K

1.3 Margins

MAXN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MAXN Yearly Profit, Operating, Gross MarginsMAXN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

More info and screens

0

2. Health

2.1 Basic Checks

MAXN does not have a ROIC to compare to the WACC, probably because it is not profitable.
MAXN has more shares outstanding than it did 1 year ago.
The number of shares outstanding for MAXN has been reduced compared to 5 years ago.
Compared to 1 year ago, MAXN has a worse debt to assets ratio.
MAXN Yearly Shares OutstandingMAXN Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
MAXN Yearly Total Debt VS Total AssetsMAXN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of -7.62, we must say that MAXN is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -7.62, MAXN is doing worse than 81.82% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -7.62
ROIC/WACCN/A
WACC5.68%
MAXN Yearly LT Debt VS Equity VS FCFMAXN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

A Current Ratio of 0.78 indicates that MAXN may have some problems paying its short term obligations.
With a Current ratio value of 0.78, MAXN is not doing good in the industry: 94.55% of the companies in the same industry are doing better.
MAXN has a Quick Ratio of 0.78. This is a bad value and indicates that MAXN is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.67, MAXN is doing worse than 93.64% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.78
Quick Ratio 0.67
MAXN Yearly Current Assets VS Current LiabilitesMAXN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

4

3. Growth

3.1 Past

MAXN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 84.01%, which is quite impressive.
The Revenue for MAXN has decreased by -54.68% in the past year. This is quite bad
MAXN shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -15.74% yearly.
EPS 1Y (TTM)84.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.85%
Revenue 1Y (TTM)-54.68%
Revenue growth 3Y-13.38%
Revenue growth 5Y-15.74%
Sales Q2Q%-73.96%

3.2 Future

MAXN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.42% yearly.
The Revenue is expected to grow by 38.94% on average over the next years. This is a very strong growth
EPS Next Y99.98%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year54.92%
Revenue Next 2Y38.94%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MAXN Yearly Revenue VS EstimatesMAXN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
MAXN Yearly EPS VS EstimatesMAXN Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 -200 -400 -600

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MAXN. In the last year negative earnings were reported.
Also next year MAXN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MAXN Price Earnings VS Forward Price EarningsMAXN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MAXN Per share dataMAXN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -50 -100

4.3 Compensation for Growth

A more expensive valuation may be justified as MAXN's earnings are expected to grow with 41.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MAXN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAXEON SOLAR TECHNOLOGIE

NASDAQ:MAXN (6/27/2025, 8:00:00 PM)

3.07

+0.03 (+0.99%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)N/A N/A
Inst Owners3.35%
Inst Owner Change-2.28%
Ins Owners0.5%
Ins Owner ChangeN/A
Market Cap51.88M
Analysts45
Price Target12.24 (298.7%)
Short Float %13.2%
Short Ratio4.83
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)83.1%
Min EPS beat(2)82.1%
Max EPS beat(2)84.1%
EPS beat(4)2
Avg EPS beat(4)24.23%
Min EPS beat(4)-57.06%
Max EPS beat(4)84.1%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-47.76%
Min Revenue beat(2)-79.98%
Max Revenue beat(2)-15.54%
Revenue beat(4)1
Avg Revenue beat(4)-24.68%
Min Revenue beat(4)-79.98%
Max Revenue beat(4)2.03%
Revenue beat(8)1
Avg Revenue beat(8)-14.81%
Revenue beat(12)4
Avg Revenue beat(12)-9.38%
Revenue beat(16)5
Avg Revenue beat(16)-7.75%
PT rev (1m)-78.62%
PT rev (3m)-78.62%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)15.02%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.07
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-141.63
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-19.05
FCFYN/A
OCF(TTM)-15.98
OCFYN/A
SpS41.22
BVpS-17.4
TBVpS-17.43
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -151.06%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-70.69%
ROA(5y)-50.14%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover1.85
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 120.93%
Cap/Sales 7.46%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.78
Quick Ratio 0.67
Altman-Z -7.62
F-Score2
WACC5.68%
ROIC/WACCN/A
Cap/Depr(3y)118.42%
Cap/Depr(5y)155.85%
Cap/Sales(3y)7.42%
Cap/Sales(5y)9.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.85%
EPS Next Y99.98%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-54.68%
Revenue growth 3Y-13.38%
Revenue growth 5Y-15.74%
Sales Q2Q%-73.96%
Revenue Next Year54.92%
Revenue Next 2Y38.94%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-392.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year94.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y0%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-6.3%
OCF growth 3YN/A
OCF growth 5YN/A